Status:
UNKNOWN
Epicardial Fat and Clinical Outcomes After Coronary Artery Bypass Grafting in Diabetics vs. Non Diabetics
Lead Sponsor:
University of Campania Luigi Vanvitelli
Conditions:
Diabetes
Coronary Artery Disease
Eligibility:
All Genders
18-75 years
Phase:
PHASE4
Brief Summary
Cardiovascular disease (CVD) is a group of diseases including both the heart and blood vessels, thereby including coronary heart disease (CHD). To date, diabetics have a higher incidence and prevalenc...
Detailed Description
Cardiovascular disease (CVD) is a group of diseases that include both the heart and blood vessels, thereby including coronary heart disease (CHD) and coronary artery disease (CAD), and acute coronary ...
Eligibility Criteria
Inclusion
- patients aged \>18, \<75, left ventricle ejection fraction (LVEF) \>50%, multivessel coronary disease detected by coronarography, indication to receive a CABG, stable CAD. All diabetics and non diabetics.
Exclusion
- acute myocardial infarction, heart failure, neoplastic disease, chronic diseases that may affect the inflammatory profile both systemic and epicardial (cancer, chronic intestinal inflammation, hepatitis, AIDS); life expectancy \< 6 months, previous CABG and/or other open heart surgery intervention, acute coronary syndrome
Key Trial Info
Start Date :
September 20 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 20 2019
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT03360981
Start Date
September 20 2017
End Date
August 20 2019
Last Update
December 5 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Raffaele Marfella
Naples, Italy, 80128